Technical and Administrative Management Services in Support of Domestic and International Collaborative Research Efforts
支持国内和国际合作研究工作的技术和行政管理服务
基本信息
- 批准号:10215364
- 负责人:
- 金额:$ 71.67万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-10-01 至 2021-07-12
- 项目状态:已结题
- 来源:
- 关键词:AIDS/HIV problemAntiviral AgentsBirthBlindedCaringCataractCataract ExtractionChildClinicalClinical ResearchCommunicable DiseasesCountyCross-Sectional StudiesDisease susceptibilityDouble-Blind MethodEbolaEbola Hemorrhagic FeverEbola VaccinesEbola virusEyeFundingGeneticGenotypeHIV InfectionsHumoral ImmunitiesImmunologic MonitoringImmunologicsIndividualInfectionInternationalLiberiaNatural HistoryNeurologyNewly DiagnosedOffice of Administrative ManagementOutcomeParasitesPhasePlacebosPlasmodiumPregnant WomenProspective cohort studyProtocols documentationRandomizedRandomized Controlled Clinical TrialsRegimenResearchResearch InfrastructureSafetySeminal fluidSerologicalServicesSeveritiesSurvivorsTissuesVaccinationVariantViralcase controlcohortdisorder riskfollow-upmalemortalityphase II trialprospectiveremdesivirresponsescreeningtrial comparingtwo-arm trialvaccine responseviral RNAvirology
项目摘要
This funding supports core clinical research infrastructure to facilitate multicenter, randomized, controlled clinical trials on Ebola virus and other infectious diseases in Liberia.
这笔资金支持核心临床研究基础设施,以促进利比里亚针对埃博拉病毒和其他传染病的多中心、随机、受控临床试验。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SOMER HAMRICK其他文献
SOMER HAMRICK的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SOMER HAMRICK', 18)}}的其他基金
Technical and Administrative Management Services in Support of Domestic and International Collaborative Research Efforts
支持国内和国际合作研究工作的技术和行政管理服务
- 批准号:
10215363 - 财政年份:2018
- 资助金额:
$ 71.67万 - 项目类别:
Technical and Administrative Management Services in Support of Domestic and International Collaborative Research Efforts
支持国内和国际合作研究工作的技术和行政管理服务
- 批准号:
10329794 - 财政年份:2018
- 资助金额:
$ 71.67万 - 项目类别:
Technical and Administrative Management Services in Support of Domestic and International Collaborative Research Efforts
支持国内和国际合作研究工作的技术和行政管理服务
- 批准号:
10464865 - 财政年份:2016
- 资助金额:
$ 71.67万 - 项目类别:
相似海外基金
Development of a new generation of antiviral agents that are effective against drug-resistant viruses and prevent serious illness and sequelae.
开发新一代抗病毒药物,可有效对抗耐药病毒并预防严重疾病和后遗症。
- 批准号:
23K18186 - 财政年份:2023
- 资助金额:
$ 71.67万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
A versatile structure-based therapeutic platform for development of VHH-based antitoxin and antiviral agents
一个多功能的基于结构的治疗平台,用于开发基于 VHH 的抗毒素和抗病毒药物
- 批准号:
10560883 - 财政年份:2023
- 资助金额:
$ 71.67万 - 项目类别:
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
- 批准号:
10730692 - 财政年份:2021
- 资助金额:
$ 71.67万 - 项目类别:
Design and synthesis of nucleosides to develop antiviral agents and oligonucleotide therapeutics
设计和合成核苷以开发抗病毒药物和寡核苷酸疗法
- 批准号:
21K06459 - 财政年份:2021
- 资助金额:
$ 71.67万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
- 批准号:
10189880 - 财政年份:2021
- 资助金额:
$ 71.67万 - 项目类别:
Computer-aided identification and synthesis of novel broad-spectrum antiviral agents
新型广谱抗病毒药物的计算机辅助鉴定和合成
- 批准号:
2404261 - 财政年份:2020
- 资助金额:
$ 71.67万 - 项目类别:
Studentship
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
- 批准号:
10222540 - 财政年份:2020
- 资助金额:
$ 71.67万 - 项目类别:
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
- 批准号:
10669717 - 财政年份:2020
- 资助金额:
$ 71.67万 - 项目类别:
Association between sedentary lifestyle and liver cancer development in hepatitis C patients treated with direct-acting antiviral agents
接受直接抗病毒药物治疗的丙型肝炎患者久坐的生活方式与肝癌发展之间的关系
- 批准号:
20K10713 - 财政年份:2020
- 资助金额:
$ 71.67万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
- 批准号:
10174522 - 财政年份:2020
- 资助金额:
$ 71.67万 - 项目类别:














{{item.name}}会员




